At a glance
- Originator Nonindustrial source
- Class Analgesics
- Mechanism of Action Alpha 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Pain in France (Unknown route)
- 17 Sep 1996 New profile
- 17 Sep 1996 Preclinical development for Pain in France (Unknown route)